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Abstract
Objective: The objective of this selective EBM review is to determine whether or not
therapeutic hypothermia is an effective treatment in improving survival rates in pediatric patients
that have suspected brain injuries.
Study Design: Two randomized control trials and one cohort analysis published in 2015 to 2016
were selected based on their relevance to the clinical question.
Data Sources: Studies were obtained by searching PubMed, OVID, Medline databases. All
articles were published in English and peer viewed journals.
Outcome Measured: The outcome measured was survival rates at 12-month post injury compared
between the groups that received therapeutic hypothermia or normotherapy in pediatric patients.
Results: All three studies reviewed did not find a statistically significant improvement in survival
rates at 12 months with the use of therapeutic hypothermia in pediatric patients with brain
injuries. There was a variation between studies on therapeutic hypothermia technique and
duration utilized, injury to treatment times, as well as type of brain injury sustained.
Conclusions: The results of the systematic review of the three studies showed that therapeutic
hypothermia does not improve survival rates at the 12-month mark following an acute brain
injury in pediatric patients at this time. However, it should be stated that further investigation in
the subject matter should include similar hypothermia therapy techniques, faster injury to
treatment times, and larger sample sizes.
Keywords: Therapeutic hypothermia, randomized, pediatric, traumatic brain injury, drowning,
pediatric cardiac arrest.
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Introduction
It’s cool to be cold, or at least that is the thinking with therapeutic hypothermia. Targeted
temperature management (TTM) or hypothermia therapy is the intentional lowering of the core
body temperature from its normal temperature of 37°C to a range of 32° to 34°C in an effort to
improve brain injury outcomes1. Hypothermia has been used to manage problems that arise from
global ischemia and reperfusion injuries2. Brain injuries can be considered such events and are
defined as non-degenerative non-congenital insults to brain tissue that can possibly cause
permanent or temporary impairment of cognitive, physical, psychosocial functions with an
associated diminished or altered state of consciousness1.
Brain injuries can be divided into two categories, primary and secondary. Primary brain
injuries include direct impacts with the brain such as a concussion, contusion, coup-contrecoup,
and diffuse axonal injury. Primary injuries also involve insults to brain tissue such as hypoxia or
anoxic injuries either due to an illness, disease process, or cardiac arrest. Secondary brain
injuries refer to the changes that occur within hours to days after a primary brain injury. These
changes include endogenous cascade of cellular and biochemical events that trigger excessive
amounts of the excitatory amino acid glutamate3. This excessive amount triggers neuronal cell
death and is termed “excitotoxicity”3. The destructive cascade appears to be not only dependent
on severity, but also age-dependent in which immature cells are more susceptible making
pediatric patients more at risk3.
The severity of a brain injury is also clinically calculated during a neurological
assessment called the Glasgow Coma Scale (GCS) where a patient’s motor, verbal, and eye
response are all rated and scored. A score is ranged between 3 and 15, with 15 being normal. A
score of 13-16 is considered a mild injury, 9 to 12 moderate, and 3 to 8 being severe3.
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Brain injuries are the most common cause of morbidity and mortality in children and
encompass 90% of all pediatric injury related deaths4. In a 2013 study by Robertson et al, it was
discovered that across 24 pediatric intensive care units the average bill in treating brain injuries
was $46,784 for an average 5.3 day stay4. Hospital stays ranged from 1 to 5,324 days and the
most expensive bill costing $7.8 million4.
The issue with managing brain injuries in pediatrics is appropriately treating the
secondary injury. Currently, there is no standard of therapy for this secondary process or halting
the excitatory process associated with neuronal cell death3. However, hypothermia has been
shown in experimental trials to be neuroprotective against secondary brain injury by decreasing
cerebral metabolism, inflammation, and excitotoxicity3. The only absolute contraindication to
hypothermic therapy is situations in which aggressive treatment is not warranted2. It has been
suggested that therapeutic hypothermia be utilized in pediatric brain injuries to protect
developing brains and decrease the economic burden associated with these injuries.
Objective
The objective of this selective EBM review is to determine whether or not “therapeutic
hypothermia is an effective treatment in improving survival rates in pediatric patients that have
suspected brain injuries.”
Search Strategy Methods
This investigation looked at two randomized controlled trials (RCT) and one cohort
study. Selection for the studies used were based on several factors. The population was any
pediatric patient, ages 48 hours old to 18 years old that had suspected brain injuries. The brain
injuries included both hypoxic events and physical head trauma. Within the studies reviewed this
was demonstrated as children who required chest compressions for at least 2 minutes and were
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mechanically ventilated, had a GCS less than 9, or an abnormal CT scan. The interventions in all
three studies included the use of therapeutic hypothermia. Typically, this included an array of
techniques that centered on cooling a patient’s body temperature to between 32°and 34°C for a
period of time. This group was compared to patients who underwent normothermic treatment.
These patients kept a strict body core temperatures of 36°to 37° C and were strictly monitored.
The outcomes addressed in reviewing the studies included individual 12-month post injury
survival status.
Studies were obtained by searching PubMed, OVID, Medline Database during 2016. Key
words used were “therapeutic hypothermia”, “randomized”, “pediatrics”, “traumatic brain
injury”, “drowning”, and “pediatric cardiac arrest”. All articles were published in English and
were peer reviewed. The author conducted all the appropriate research on the subject and
ultimately articles were selected based on relevance to clinical questions with patient oriented
outcomes. Inclusion criteria for articles included pediatric patients ages 18 years old or younger
and therapeutic use of hypothermia for a brain injury. Exclusion criteria were absent survival
rates at the 12-month mark, older population, and absence of suspected brain injury. The
inclusion and exclusion criteria for each article is listed below (see Table 1). Statistical analysis
for this review included calculations concerning the control event rate (CER), experimental event
rate (EER), relative risk reduction (RRR), absolute risk reduction (ARR), and numbers needed to
treat (NNT). All which were calculated by the author using dichotomous data found in each
study.
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Table 1: Demographics & Characteristics of Included Studies
Study

Type

Number
of
Patients

Age

Inclusion
Criteria

Exclusion
Criteria

Withdrawn

Interventions

Beca5

RCT

55

1 to 15
y.o.

Children
who could be
randomized,
mechanically
ventilated,
GCS less
than 9, and
who had a
abnormal CT
scan

5

Induced
therapeutic
hypothermia 3233∘C for 72
hours, rewarmed
after 72 hours.
Rate of
rewarming 0.5∘C
every 3 hours

Moler6

RCT

295

48
hours
old to
18 y.o.

Children
with cardiac
arrest that
required
chest
compressions
for at least 2
minutes and
remained on
dependent on
mechanical
ventilation

Children who
could not be
randomized within
6 hours, who had
penetrating brain
injury, who had
fixed dilated
pupils with GCS
of 3, had a
cervical spinal
cord injury, had a
disability prior to
injury, acute
epidural
hematoma,
refractory shock,
or suspected nonaccidental trauma
(NAT).
Inability to
randomize within
6 hours, GCS
score of 5 or 6,
decision by
clinical team to
with withhold
aggressive
treatment, or
sustained major
trauma

8

Hypothermia 32.0
- 34.0∘C for 48
hour, rewarmed
over 16 hours or
longer to 36.8∘C
for a total of 120
hours TTM

Moler7

Cohort

74

48
hours
old to
18 y.o.

Children
who
sustained
chest
compressions
for at least 2
minutes and
remained
comatose on
a mechanical
ventilation,
and was a
victim of
drowning.

Inability to
randomize within
6 hours, GCS
score of 5 or 6,
motor response
subscale 1 to 6
score, lack of
commitment or
aggressive care,
associated major
trauma, or
drowning in ice
covered water

5

Hypothermia 32.0
- 34.0∘C for 48
hour, rewarmed
over 16 hours or
longer to 36.8∘C
for a total of 120
hours TTM

4
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Outcomes Measured
The outcome measured in this review was survival at the 12-month post injury mark.
Mortality was compared between the groups that received therapeutic hypothermia to
normothermic therapy in pediatric patients with brain injuries.
Results
All three studies gave insight on survival rates of pediatric patients with brain injuries
with the use of therapeutic hypothermia versus normothermia. The articles reviewed provided
dichotomous data that could be used for calculations of RRR, ARR, and NNT at the desired time
frame of 12 months status post injury per individual patient.
In the Beca et al study 92 patients were eligible and 55 were recruited for randomization
from 8 pediatric intensive care units (PICU) in Australia, New Zealand, and Canada5. This study
utilized temperature control through a cooling blanket and IV fluid bolus and monitored via a
temperature probe in the esophagus. Hypothermia was maintained for a minimum of 72 hours
and rewarming was induced at a rate of 0.5°c every three hours5. During the course of treatment
5 had management protocol violations and were removed from the study’s results5. Of the
remaining 50 patients, 24 patients were randomized to therapeutic hypothermia and 26 patients
to normothermia5. The trial reported that at 12 months 4% of the normothermia group and 13%
of the hypothermia group had died. The results were not significantly different (p = 0.34)5.
Extracted information for use of therapeutic hypothermia demonstrated a RRR of 2.25% and an
ARR of 9%. The numbers needed to treat was 12, meaning that 12 patients needed to be treated
with therapeutic hypothermia in order to see a benefit in survival compared to control (Table 2).
Additionally, this study found no difference in complication rates between the two groups of
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treatment over the course of 12 months, but did cite that rewarming is a difficult process with
hypotension as a common issue5.
In the Moler et al study in 2015, 295 patients enrolled in the randomized controlled study
at 38 children’s hospitals across United States and Canada6. The therapeutic hypothermia group
was managed for a total of 120 hours and achieved 48 hours of temperatures at 33ºC using
Blanketrol III cooling units applied anteriorly and posteriorly6. Patients were rewarmed over 16
hours or longer to 36.8°C6. Temperature was monitored via esophageal, rectal, or bladder device.
3 patients achieved temperature management through extracorporeal membrane oxygenation
(ECMO). The normothermia group was aggressively monitored for 120 hours at 36.8°C6. At 12
months post incident mortality was assessed amongst 287 patients. Survival was reported as 38%
of the therapeutic hypothermia patients and 29% of the normothermia with a relative likelihood
of 1.29, a 95% confidence interval (CI) 0.93 to 1.79, (P = 0.13)6. Therefore, there was no
significant difference between groups. Additionally, obtained information from the study
provided a RRR of -12.7% and an ARR of -9.0%. The numbers needed to treat was -11 (Table
2). A negative number means that for every 11 patients who were treated with therapeutic
hypothermia there was one fewer incidence of survival in the normothermia group. The study
reports that mortality at 28 days status post incident did not significantly differ between the
groups, 57% hypothermia vs 67% normothermia (P=0.08)6. The primary cause of death for both
groups of these patients were brain death or withdrawal of life sustaining therapy due to poor
neurological prognosis6. The incidence of complications such as bleeding, infection, and
arrhythmias were similar among both groups6. However, hypokalemia and thrombocytopenia
occurred more frequently in the hypothermia group, and renal replacement therapy more
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common in the normothermia group6. Overall, this study fails to prove that therapeutic
hypothermia is beneficial in improving survival rates.
The Moler et al cohort study of 2016 was conducted selectively on pediatric drownings.
At 24 PICUs 74 patients were reviewed7. This study used 48 hours of temperatures at 33ºC using
Blanketrol III cooling units applied anteriorly and posteriorly7. Patients were rewarmed over 16
hours or longer to 36.8°C7. Temperature was monitored via esophageal, rectal, or bladder device.
No ECMO was used. At the individual 12-month status post incident mark, 5 patients’ status
was unknown. Of the remaining 69 patients, 49% of the hypothermia group and 42% of the
normothermia group were alive at 12 months with a 95% CI, 0.68-1.99 (p=0.58) that
demonstrate the results were not statistically significant7. Extracted data gave a RRR of -11%, an
ARR of -6.5%, and a -15 NNT (Table 2). The negative number to treat indicates that for every
15 patients treated with hypothermia there was one fewer incident in the normothermia group.
Conversely, this study is limited by the relative small sample size. As with the other studies it
coincides to the belief that therapeutic hypothermia does not appear to improve survival rates at
12 months.
Table 2: Comparison of outcomes measured of included studies
Study

Number of Patients

P-

RRR

ARR

value

(%)

(%)

CI

NNT

Beca5

50

N/A

0.34*

2.25%

8.70%

12

Moler6

287

0.93 - 1.79

0.13

-12.70%

-9.00%

-11

Moler7

69

0.68 - 1.99

0.58

-11.00%

-6.50%

-15

*Data based off deaths rather than survival
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Discussion
The goal of this systematic review was to determine if therapeutic hypothermia improved
survival rates. Therefore, it should be noted that the above studies have their own limitations to
proving a true benefit of therapeutic hypothermia. Sample size is a crucial factor for creating
statistically significant data. Both Beca et al and Moler et al 2016 contained small sample sizes
respectfully. Each had under 70 total participants that were available for review at the end of 12
months5,7. Among studies reviewed there was also insight that a variation of conducting
therapeutic hypothermia may have occurred and different hospitals might have used different
protocols. The time of total TTM varied, methods of conducting the reduced body temperature,
method of monitoring, and rewarming process differ just among the three studies reviewed.
Another limitation to the studies in review was time to treatment. The goal of medical
therapy is to reduce the secondary injuries associated with a brain injury. In reviews of the Beca
et al study the median time from injury to target temperature for hypothermia patients was 9.3
hours5. The average timeframe for Moler et al 2016 cohort study was 5.8 hours from return of
circulation to treatment initiation7. The suspected area of delay to treatment is obtaining consent
during a very critical and emotional timeframe. Medical treatment requires providers to obtain
consent before initiating treatment. The Beca et al study mentions foregoing consent by
mentioning that emergency care research meets criteria to override or defer consent when there is
a delay. The study included this type of thinking with 8 patients at 4 of the research sites, as
patients were randomized without consent5. The deferred consent proved no problems later for
both researchers and ethic committees. Initiating therapy sooner could have a positive effect and
slow the secondary brain injury destructive process. In turn this could improve survival of these
pediatric patients and should be sought after in future studies.
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Conclusions
The articles included in this systematic review justify the conclusion that therapeutic
hypothermia in pediatric brain injuries does not improve survival rates. However, since the
research supports use in the adult population further investigation can be justified. Additional
studies are warranted, especially with a reduction in injury to treatment times. Standardized
hypothermic techniques in a larger sample could show similar results in pediatric use when
compared to adults. The current use of therapeutic hypothermia in children doesn’t work as
hoped, but it would be a lot cooler if it did in the future.

9

References
1.

Dawodu S. Traumatic Brain Injury (TBI) - Definition, Epidemiology, Pathophysiology:
Overview, Epidemiology, Primary Injury, Medscape website. 2017.
http://emedicine.medscape.com/article/326510-overview. Published August 2017.
Accessed October 2017.

2.

Rittenberger J., Callaway C. Post-cardiac management in adults. Uptodate website.
http://www.uptodate.com/contents/post-cardiac-arrest-management-in-adults. Published
September 2017. Accessed December 2017.

3.

Huh JW, Raghupathi R. New concepts in treatment of pediatric traumatic brain
injury. Anesthesiology clinics. 2009;27(2):213-240. doi:10.1016/j.anclin.2009.05.006.

4.

Robertson BD, McConnel CE, Green S. Charges associated with pediatric head injuries: a
five year retrospective review of 41 pediatric hospitals in the US. Journal of Injury and
Violence Research. 2013;5(1):51-60. doi:10.5249/jivr.v5i1.205.

5.

Beca J, McSharry B, Erickson S, et al. Hypothermia for traumatic brain injury in
Children—A phase II randomized controlled trial. Critical Care Medicine.
2015;43(7):1458-1466. doi: 10.1097/CCM.0000000000000947.

6.

Moler FW, Silverstein FS, Holubkov R, et al. Therapeutic hypothermia after out-ofhospital cardiac arrest in children. New England Journal of Medicine. 2015;372(20):1898–
1908. http://doi:10.1056/nejmoa1411480.

7.

Moler FW, Hutchison J, Nadkarni V, et al. Targeted temperature management after
pediatric cardiac arrest due to drowning: Outcomes and complications. Pediatric critical
care medicine: a journal of the Society of Critical Care Medicine and the World
Federation of Pediatric Intensive and Critical Care Societies. 2016;17(8):712–20
http://www.ncbi.nlm.nih.gov/pubmed/27362855. doi: 10.1097/PCC.0000000000000763.

